ong-term clinical and radiological outcome of Richards type II patellofemoral arthroplasty for isolated patellofemoral arthritis.
Completed
- Conditions
- kneecap arthrosispatellofemoral arthrosis1002321310005944
- Registration Number
- NL-OMON30461
- Lead Sponsor
- Deventer Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Not applicable
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Revision of the patellofemoral prosthesis to patellofemoral or total knee<br /><br>arthroplasty, for any reason.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The clinical, functional and radiological results after patellofemoral<br /><br>arthroplasty, and progression of femorotibial osteoarthritis.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biological pathways influence long-term success of Richards type II patellofemoral arthroplasty in isolated patellofemoral arthritis?
How does Richards type II arthroplasty compare to total knee arthroplasty in managing isolated patellofemoral arthritis outcomes?
Which predictive biomarkers identify optimal candidates for Richards type II arthroplasty in patellofemoral arthritis patients?
What long-term adverse events are associated with Richards type II patellofemoral arthroplasty and their management strategies?
Are there adjunctive pharmacological therapies improving outcomes when combined with Richards type II arthroplasty for patellofemoral arthritis?